• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

EXOSC3 突变的婴儿感染 SARS-CoV2 引起的非典型溶血尿毒综合征。

Atypical hemolytic uremic syndrome induced by SARS-CoV2 infection in infants with EXOSC3 mutation.

机构信息

Clementine Kinderhospital, Theobald-Christ-Strasse 16, 60316, Frankfurt am Main, Germany.

Bürgerhospital, Frankfurt am Main, Germany.

出版信息

Pediatr Nephrol. 2022 Nov;37(11):2781-2784. doi: 10.1007/s00467-022-05566-6. Epub 2022 May 6.

DOI:10.1007/s00467-022-05566-6
PMID:35522339
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9072151/
Abstract

BACKGROUND

Atypical hemolytic uremic syndrome (aHUS) is a rare disease characterized by systemic thrombotic microangiopathy mainly in the kidneys and mostly due to genetic disorders leading to uncontrolled activation of the complement system. Severe complications of SARS-CoV2 infection are linked to microvascular injury and complement activation is suspected to play a role in the pathogenesis of endothelial cell damage in severe COVID-19.

METHODS

We present the first two cases of aHUS triggered by SARS-CoV-2 infection in two unrelated infants with the same mutation in the RNA exosome gene EXOSC3. This mutation is known to cause pontocerebellar hypoplasia type 1b, an autosomal-recessive neurodegenerative disease. So far, no kidney involvement in affected persons was reported.

RESULTS

As eculizumab treatment was unsuccessful and complement-mediated disorders were ruled out, we suppose that the atypical HUS in our two patients is not due to complement-mediated thrombotic microangiopathy but rather due to a dysfunction of the RNA exosome.

CONCLUSIONS

The RNA exosome is crucial for the precise processing and degradation of nuclear and cytoplasmatic RNA. We suspect that the SARS-CoV-2 infection led to changes in RNA that could not be offset by the defective RNA exosome in our two patients. The accumulation/wrong processing of the viral RNA must have led to the endothelial cell damage resulting in aHUS. This would be a new - "RNA-induced" - mechanism of aHUS.

摘要

背景

非典型溶血尿毒综合征(aHUS)是一种罕见疾病,以全身血栓性微血管病为特征,主要发生在肾脏,主要由导致补体系统失控激活的遗传疾病引起。SARS-CoV2 感染的严重并发症与微血管损伤有关,补体激活被怀疑在严重 COVID-19 中内皮细胞损伤的发病机制中发挥作用。

方法

我们介绍了由 SARS-CoV-2 感染引发的首例两例不相关婴儿的 aHUS,这两例婴儿均存在 RNA 外切体基因 EXOSC3 的相同突变。该突变已知会导致桥脑小脑发育不良 1b 型,一种常染色体隐性神经退行性疾病。迄今为止,受影响者的肾脏未受累。

结果

由于依库珠单抗治疗无效且排除了补体介导的疾病,我们推测我们的两名患者的非典型 HUS 不是由于补体介导的血栓性微血管病引起的,而是由于 RNA 外切体的功能障碍引起的。

结论

RNA 外切体对于核和细胞质 RNA 的精确加工和降解至关重要。我们怀疑 SARS-CoV-2 感染导致了 RNA 的变化,而我们的两名患者的有缺陷的 RNA 外切体无法抵消这些变化。病毒 RNA 的积累/错误处理必定导致了内皮细胞损伤,从而导致 aHUS。这将是 aHUS 的一种新的 -“RNA 诱导”-机制。

相似文献

1
Atypical hemolytic uremic syndrome induced by SARS-CoV2 infection in infants with EXOSC3 mutation.EXOSC3 突变的婴儿感染 SARS-CoV2 引起的非典型溶血尿毒综合征。
Pediatr Nephrol. 2022 Nov;37(11):2781-2784. doi: 10.1007/s00467-022-05566-6. Epub 2022 May 6.
2
Mutations in Genes Encoding Subunits of the RNA Exosome as a Potential Novel Cause of Thrombotic Microangiopathy.RNA 外切体亚基编码基因的突变可能是血栓性微血管病的一个新病因。
Int J Mol Sci. 2024 Jul 11;25(14):7604. doi: 10.3390/ijms25147604.
3
A case-based narrative review of pregnancy-associated atypical hemolytic uremic syndrome/complement-mediated thrombotic microangiopathy.妊娠相关性非典型溶血尿毒综合征/补体介导的血栓性微血管病的病例叙述性综述。
Kidney Int. 2024 May;105(5):960-970. doi: 10.1016/j.kint.2023.12.021. Epub 2024 Feb 24.
4
[A hemolytic episode following COVID-19 in a case with atypical hemolytic uremic syndrome].[1例非典型溶血性尿毒症综合征患者新冠病毒病后的溶血发作]
Rinsho Ketsueki. 2022;63(3):224-228. doi: 10.11406/rinketsu.63.224.
5
Atypical hemolytic uremic syndrome triggered by mRNA vaccination against SARS-CoV-2: Case report.mRNA 疫苗接种引发的非典型溶血尿毒综合征:病例报告。
Front Immunol. 2022 Sep 28;13:1001366. doi: 10.3389/fimmu.2022.1001366. eCollection 2022.
6
Atypical Hemolytic Uremic Syndrome after SARS-CoV-2 Infection: Report of Two Cases.新型冠状病毒感染后非典型溶血尿毒综合征:两例报告。
Int J Environ Res Public Health. 2022 Sep 11;19(18):11437. doi: 10.3390/ijerph191811437.
7
Post-Transplant Thrombotic Microangiopathy due to a Pathogenic Mutation in Complement Factor I in a Patient With Membranous Nephropathy: Case Report and Review of Literature.膜性肾病患者因补体因子I致病突变导致的移植后血栓性微血管病:病例报告及文献复习
Front Immunol. 2022 May 26;13:909503. doi: 10.3389/fimmu.2022.909503. eCollection 2022.
8
An effective treatment of atypical hemolytic uremic syndrome with plasma exchange and eculizumab: A case report.血浆置换联合依库珠单抗治疗非典型溶血性尿毒症综合征1例报告
Transfus Apher Sci. 2015 Jun;52(3):314-6. doi: 10.1016/j.transci.2015.01.006. Epub 2015 Jan 12.
9
A retrospective study of pregnancy-associated atypical hemolytic uremic syndrome.妊娠相关性非典型溶血尿毒综合征的回顾性研究。
Kidney Int. 2018 Feb;93(2):450-459. doi: 10.1016/j.kint.2017.06.022. Epub 2017 Sep 12.
10
Genetics of atypical hemolytic uremic syndrome (aHUS).非典型溶血性尿毒症综合征(aHUS)的遗传学。
Semin Thromb Hemost. 2014 Jun;40(4):422-30. doi: 10.1055/s-0034-1375296. Epub 2014 May 5.

引用本文的文献

1
Atypical hemolytic uremic syndrome with a variant following COVID-19: a case report.新型冠状病毒肺炎后出现变异型的非典型溶血性尿毒症综合征:一例报告
Front Pediatr. 2025 Jan 23;13:1507727. doi: 10.3389/fped.2025.1507727. eCollection 2025.
2
Mutations in Genes Encoding Subunits of the RNA Exosome as a Potential Novel Cause of Thrombotic Microangiopathy.RNA 外切体亚基编码基因的突变可能是血栓性微血管病的一个新病因。
Int J Mol Sci. 2024 Jul 11;25(14):7604. doi: 10.3390/ijms25147604.
3
Dysregulation of Immune Cell Subpopulations in Atypical Hemolytic Uremic Syndrome.免疫细胞亚群失调在非典型溶血尿毒综合征中的作用。
Int J Mol Sci. 2023 Jun 11;24(12):10007. doi: 10.3390/ijms241210007.
4
Pitfalls of Thrombotic Microangiopathies in Children: Two Case Reports and Literature Review.儿童血栓性微血管病的陷阱:两例病例报告及文献综述
Diagnostics (Basel). 2023 Mar 24;13(7):1228. doi: 10.3390/diagnostics13071228.
5
Hemolytic uremic syndrome in the setting of COVID-19 successfully treated with complement inhibition therapy: An instructive case report of a previously healthy toddler and review of literature.新型冠状病毒肺炎相关溶血尿毒综合征经补体抑制治疗成功治愈:一例既往健康幼儿的病例报告及文献复习
Front Pediatr. 2023 Feb 15;11:1092860. doi: 10.3389/fped.2023.1092860. eCollection 2023.

本文引用的文献

1
Increased complement activation is a distinctive feature of severe SARS-CoV-2 infection.补体激活增加是严重 SARS-CoV-2 感染的一个显著特征。
Sci Immunol. 2021 May 13;6(59). doi: 10.1126/sciimmunol.abh2259.
2
Toddler With New Onset Diabetes and Atypical Hemolytic-Uremic Syndrome in the Setting of COVID-19.幼儿在感染 COVID-19 的情况下出现新发糖尿病和非典型溶血尿毒综合征。
Pediatrics. 2021 Feb;147(2). doi: 10.1542/peds.2020-016774. Epub 2020 Oct 9.
3
Eculizumab treatment for renal failure in a pediatric patient with COVID-19.依库珠单抗治疗 COVID-19 儿童患者肾衰竭。
J Nephrol. 2020 Dec;33(6):1373-1376. doi: 10.1007/s40620-020-00858-2. Epub 2020 Sep 26.
4
Direct activation of the alternative complement pathway by SARS-CoV-2 spike proteins is blocked by factor D inhibition.SARS-CoV-2 刺突蛋白直接激活替代补体途径被因子 D 抑制所阻断。
Blood. 2020 Oct 29;136(18):2080-2089. doi: 10.1182/blood.2020008248.
5
Is the COVID-19 thrombotic catastrophe complement-connected?新冠病毒引发的血栓性灾难与补体系统有关吗?
J Thromb Haemost. 2020 Nov;18(11):2812-2822. doi: 10.1111/jth.15050. Epub 2020 Sep 18.
6
SnapShot: The RNA Exosome.快照:RNA 外切体。
Cell. 2019 Sep 19;179(1):282-282.e1. doi: 10.1016/j.cell.2019.09.005.
7
The RNA exosome and RNA exosome-linked disease.RNA 外切体与 RNA 外切体相关疾病
RNA. 2018 Feb;24(2):127-142. doi: 10.1261/rna.064626.117. Epub 2017 Nov 1.
8
Mutations of EXOSC3/Rrp40p associated with neurological diseases impact ribosomal RNA processing functions of the exosome in .与神经疾病相关的EXOSC3/Rrp40p突变影响外切体在核糖体RNA加工中的功能。
RNA. 2017 Apr;23(4):466-472. doi: 10.1261/rna.060004.116. Epub 2017 Jan 4.
9
Eculizumab as first-line therapy for atypical hemolytic uremic syndrome.依库珠单抗作为一线治疗用于非典型溶血性尿毒症综合征。
Pediatrics. 2014 Jun;133(6):e1759-63. doi: 10.1542/peds.2013-1787.
10
Homozygous EXOSC3 mutation c.92G→C, p.G31A is a founder mutation causing severe pontocerebellar hypoplasia type 1 among the Czech Roma.纯合子EXOSC3突变c.92G→C,p.G31A是一种奠基者突变,在捷克罗姆人群体中导致严重的1型脑桥小脑发育不全。
J Neurogenet. 2013 Dec;27(4):163-9. doi: 10.3109/01677063.2013.814651. Epub 2013 Jul 25.